Compare Tilray Brands Inc (TLRY) vs 10X Genomics Inc (TXG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tilray Brands Inc vs 10X Genomics Inc — how do they compare? Tilray Brands Inc trades at $4.24 (market cap $524.07M), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: 10X Genomics Inc is far larger — about 10.5× Tilray Brands Inc's market cap, and 10X Genomics Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| TLRY | TXG | |
|---|---|---|
Market Cap | $524.07M | $5.48B |
Sector | Health | Health |
52-Week High | $21.00 | $45.80 |
52-Week Low | $4.23 | $11.34 |
Enterprise Value | $621.22M | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →
